These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 32870478)
1. Efficacy of Chinese Medicine Acupoint Application Combined with Montelukast on Children with Perennial Allergic Rhinitis: A Randomized Controlled Trial. Li YJ; Zong M; Ding LF; Rui XQ; Ma BY; Qin LP Chin J Integr Med; 2020 Nov; 26(11):845-852. PubMed ID: 32870478 [TBL] [Abstract][Full Text] [Related]
2. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis. Kim MK; Lee SY; Park HS; Yoon HJ; Kim SH; Cho YJ; Yoo KH; Lee SK; Kim HK; Park JW; Park HW; Chung JH; Choi BW; Lee BJ; Chang YS; Jo EJ; Lee SY; Cho YS; Jee YK; Lee JM; Jung J; Park CS Clin Ther; 2018 Jul; 40(7):1096-1107.e1. PubMed ID: 29945738 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of montelukast for treating perennial allergic rhinitis. Philip G; Williams-Herman D; Patel P; Weinstein SF; Alon A; Gilles L; Tozzi CA; Dass SB; Reiss TF Allergy Asthma Proc; 2007; 28(3):296-304. PubMed ID: 17619558 [TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895 [TBL] [Abstract][Full Text] [Related]
5. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Nayak A; Langdon RB Drugs; 2007; 67(6):887-901. PubMed ID: 17428106 [TBL] [Abstract][Full Text] [Related]
6. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306 [TBL] [Abstract][Full Text] [Related]
7. Chinese medicine acupoint herbal patching for allergic rhinitis: a randomized controlled clinical trial. Hsu WH; Ho TJ; Huang CY; Ho HC; Liu YL; Liu HJ; Lai NS; Lin JG Am J Chin Med; 2010; 38(4):661-73. PubMed ID: 20626052 [TBL] [Abstract][Full Text] [Related]
8. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis. Krishnamoorthy M; Mohd Noor N; Mat Lazim N; Abdullah B Drugs; 2020 Nov; 80(17):1831-1851. PubMed ID: 32915441 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Nayak AS; Philip G; Lu S; Malice MP; Reiss TF; Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of acupuncture at three nasal acupoints plus acupoint application for perennial allergic rhinitis: A multicenter, randomized controlled trial protocol. Shou Y; Hu L; Zhang C; Xu S; Jin Q; Huang L; Li B; Yuan L; Xu S; Zhang K; Jiang H; Zhang B Trials; 2020 Jan; 21(1):110. PubMed ID: 31992367 [TBL] [Abstract][Full Text] [Related]
12. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255 [TBL] [Abstract][Full Text] [Related]
13. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172 [TBL] [Abstract][Full Text] [Related]
14. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF; Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048 [TBL] [Abstract][Full Text] [Related]
15. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis. Cingi C; Oghan F; Eskiizmir G; Yaz A; Ural A; Erdogmus N Int Forum Allergy Rhinol; 2013 Oct; 3(10):801-6. PubMed ID: 23733270 [TBL] [Abstract][Full Text] [Related]
16. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Nathan RA; Yancey SW; Waitkus-Edwards K; Prillaman BA; Stauffer JL; Philpot E; Dorinsky PM; Nelson HS Chest; 2005 Oct; 128(4):1910-20. PubMed ID: 16236835 [TBL] [Abstract][Full Text] [Related]
17. A Randomized Trial of Comparing a Combination of Montelukast and Budesonide With Budesonide in Allergic Rhinitis. Chen H; Zhang L; Lou H; Wang Y; Cao F; Wang C Laryngoscope; 2021 Apr; 131(4):E1054-E1061. PubMed ID: 31782814 [TBL] [Abstract][Full Text] [Related]
18. The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence. Santos CB; Hanks C; McCann J; Lehman EB; Pratt E; Craig TJ Allergy Asthma Proc; 2008; 29(2):140-5. PubMed ID: 18430310 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of Montelukast plus Budesonide nasal spray and Desloratadine citrate disodium in treating moderate and severe persistent allergic rhinitis]. Wang R; Zhang C Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(23):2041-3. PubMed ID: 27101674 [TBL] [Abstract][Full Text] [Related]
20. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]